Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
57
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Long Non-Coding RNA HCP5 Facilitates Cell Invasion And Epithelial-Mesenchymal Transition In Oral Squamous Cell Carcinoma By miR-140-5p/SOX4 Axis

Jianling Zhao1 Experimental Center of Dental Hospital Affiliated to Jiamusi University, Jiamusi City 154002, Heilongjiang Province, People’s Republic of China
,
Xijing Bai2 Department of Oral and Maxillofacial Surgery, Tianjin Stomatology Hospital, Tianjin City 300041, People’s Republic of China
,
Chong Feng3 Department of Orthodontics, Tianjin Stomatology Hospital, Tianjin City 300041, People’s Republic of China
,
Xinhua Shang4 Binhu Outpatient Department, Hefei Stomatological Hospital, Hefei City 230001, Anhui Province, People’s Republic of China
&
Yuli Xi5 Department of Stomatology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang City 157000, Heilongjiang Province, People’s Republic of ChinaCorrespondence[email protected]
Pages 10455-10462 | Published online: 12 Dec 2019

References

  • Rivera C.Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9 ):11884–11894. Epub 2015/12/01.26617944
  • Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5 ):309–316. Epub 2008/09/23. doi:10.1016/j.oraloncology.2008.06.00218804401
  • Renganathan A, Felley-Bosco E. Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199–222. Epub 2017/08/18.28815541
  • Liang L, Xu J, Wang M, et al. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. Cell Death Dis. 2018;9(3 ):372 Epub 2018/03/09. doi:10.1038/s41419-018-0382-729515098
  • Zhao W, Li L. SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. Pathol Res Pract. 2019;215(3 ):439–445. Epub 2018/12/18. doi:10.1016/j.prp.2018.12.00630554864
  • Wang L, Luan T, Zhou S, et al. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(9 ):4389–4403. Epub 2019/06/20. doi:10.1002/cam4.v8.931215169
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4 ):402–408. Epub 2002/02/16. doi:10.1006/meth.2001.126211846609
  • Zhang L, Meng X, Zhu XW, et al. Long non-coding RNAs in oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer. 2019;18(1 ):102 Epub 2019/05/28. doi:10.1186/s12943-019-1021-331133028
  • Savagner P .The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol.2010;21 Suppl 7:vii89–vii92. Epub 2010/10/15. doi:10.1093/annonc/mdq29220943648
  • Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6 ):1438–1449. Epub 2009/06/03. doi:10.1172/JCI3801919487820
  • da Silva SD, Morand GB, Alobaid FA, et al. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis. 2015;32(1 ):55–63. Epub 2014/12/01. doi:10.1007/s10585-014-9690-125433796
  • Jiang L, Wang R, Fang L, et al. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 2019;9(9 ):2460–2474. Epub 2019/05/28. doi:10.7150/thno.3109731131047
  • Yang C, Sun J, Liu W, et al. Long noncoding RNA HCP5 contributes to epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation and interacting with miR-139-5p. Am J Transl Res. 2019;11(2 ):953–963. Epub 2019/03/23.30899394
  • Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3 ):353–358. Epub 2011/08/02. doi:10.1016/j.cell.2011.07.01421802130
  • Peng M, Pang C. MicroRNA-140-5p inhibits the tumorigenesis of oral squamous cell carcinoma by targeting p21-activated kinase 4. Cell Biol Int. 2019 Epub 2019/08/09. doi:10.1002/cbin.11213
  • Watanabe M, Ohnishi Y, Wato M, Tanaka A, Kakudo K. SOX4 expression is closely associated with differentiation and lymph node metastasis in oral squamous cell carcinoma. Med Mol Morphol. 2014;47(3 ):150–155. Epub 2013/09/14. doi:10.1007/s00795-013-0057-524030531

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.